Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/16/2012US20120208818 Compounds useful as antagonists of ccr2
08/16/2012US20120208817 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
08/16/2012US20120208816 Organic compounds
08/16/2012US20120208815 Pim kinase inhibitors and methods of their use
08/16/2012US20120208814 Thetrahydroquinolines Derivatives As Bromodomain Inhibitors
08/16/2012US20120208813 3-carbamoyl-2-pyridone derivatives
08/16/2012US20120208812 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORS
08/16/2012US20120208811 Aminopyrazole Derivative
08/16/2012US20120208810 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
08/16/2012US20120208809 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
08/16/2012US20120208808 Pyrazolopyrimidine derivatives
08/16/2012US20120208807 Tofa analogs useful in treating dermatological disorders or conditions
08/16/2012US20120208806 Hsp90 Inhibitors
08/16/2012US20120208805 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
08/16/2012US20120208804 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
08/16/2012US20120208803 Pyrrolidine derivatives as nk2 receptor antagonists
08/16/2012US20120208801 Aminodiazepines as Toll-Like Receptor Modulators
08/16/2012US20120208800 Bromodomain Inhibitors For Treating Autoimmune And Inflammatory Diseases
08/16/2012US20120208799 Compounds
08/16/2012US20120208798 Tetrahydroquinoline Derivatives And Their Pharmaceutical Use
08/16/2012US20120208797 Pyrimidone derivatives
08/16/2012US20120208796 Heterocyclic derivatives
08/16/2012US20120208795 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders
08/16/2012US20120208794 Fused heterocyclic ring derivative and use thereof
08/16/2012US20120208793 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
08/16/2012US20120208792 Protein kinase modulators
08/16/2012US20120208791 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
08/16/2012US20120208790 Ion channel modulators and methods of use
08/16/2012US20120208789 Hydroswellable, segmented, aliphatic polyurethanes and polyurethane ureas
08/16/2012US20120208788 Tetracycline Compounds
08/16/2012US20120208787 Crystalline form of fosamprenavir calcium
08/16/2012US20120208786 Bisphosphonate compositions and methods for treating heart failure
08/16/2012US20120208785 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
08/16/2012US20120208784 Substituted propane phosphinic acid derivatives
08/16/2012US20120208783 Medicine, Food And Drink Or Feed Containing Sphingomyelin
08/16/2012US20120208782 Modulation of Growth of Bifidobacteria Using a Combination of Oligosaccharides Found in Human Milk
08/16/2012US20120208781 Aminoglycoside dosing regimens
08/16/2012US20120208780 Hybrid nanomaterials consisting of pseudorotaxanes, pseudopolyrotaxanes, rotaxanes, polyrotaxanes, nanoparticles and quantum dots
08/16/2012US20120208779 Macrolide synthesis process and solid-state forms
08/16/2012US20120208778 Avermectins and milbemycins for the treatment, prevention or amelioration of flavivirus infections
08/16/2012US20120208777 Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
08/16/2012US20120208776 Anti-neoplastic compositions comprising extracts of black cohosh
08/16/2012US20120208773 Pharmaceutical compositions with tetrabenazine
08/16/2012US20120208770 Carcinoma Homing Peptide (CHP), Its Analogs, and Methods of Using
08/16/2012US20120208769 Chemokine-Mucin Fusions Linked to Glycosylphosphatidylinositol (GPI)-Anchors in Tissue Regeneration and as Tumour Immune Adjuvants
08/16/2012US20120208767 Method to Detect or Treat Painful Bladder Syndrome based on Relation to Quinone Oxidoreductase 1
08/16/2012US20120208762 Methods of Diagnosing Diastolic Dysfunction
08/16/2012US20120208757 Use of hyaluronan for promoting angiogenesis
08/16/2012US20120208750 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
08/16/2012US20120208740 Method for preparing a solid form of acetic acid and products thereof
08/16/2012US20120207857 Compositions and Methods for Potentiation of Cancer Agents
08/16/2012US20120207856 MSH3 Expression Status Determines the Responsiveness of Cancer Cells to the Chemotherapeutic Treatment with PARP Inhibitors and Platinum Drugs
08/16/2012US20120207855 Cephalotaxine alkaloid compositions and uses thereof
08/16/2012US20120207850 Methods for Increasing the Kinetic Activity of Alcohol, Water and Other Liquids, so as to Render the Liquids More Useful in Enhancing the Alternative Cellular Energy Pathway in the Prevention and Therapy of Diseases
08/16/2012US20120207845 Pharmaceutical composition of nanoparticles
08/16/2012US20120207842 Multiparticulate l-menthol formulations and related methods
08/16/2012US20120207841 Formulations of 6-mercaptopurine
08/16/2012US20120207838 Treatment of Psoriasis Using Oral Dosage Forms of Nitrone Spin Traps
08/16/2012US20120207836 Drug delivery systems (wafer) for pediatric use
08/16/2012US20120207834 Oral antimicrobial pharmaceutical compositions
08/16/2012US20120207833 Forms of rifaximin and uses thereof
08/16/2012US20120207832 Forms of rifaximin and uses thereof
08/16/2012US20120207831 Coated solid dosage forms
08/16/2012US20120207828 Large dose ribavirin formulations
08/16/2012US20120207827 Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis
08/16/2012US20120207826 Novel parasite therapy
08/16/2012US20120207825 Pharmaceutical compositions for reducing alcohol-induced dose dumping
08/16/2012US20120207824 Orally effective methylphenidate extended release powder and aqueous suspension product
08/16/2012US20120207823 Pharmaceutical pellets comprising modified starch and therapeutic applications therefor
08/16/2012US20120207822 Compositions and methods for treatment of cardiovascular disease
08/16/2012US20120207819 Compositions and methods for wound healing
08/16/2012US20120207818 Composition for suppressing expression of target gene
08/16/2012US20120207817 Small interfering rnas and methods for prevention, inhibition and/or treatment of malignant progression of breast cancer
08/16/2012US20120207816 Transdermally Absorbable Donepezil-Containing Preparation
08/16/2012US20120207814 Aqueous patches containing diclofenac sodium
08/16/2012US20120207810 Kinase Inhibitors
08/16/2012US20120207809 Method and system for effecting changes in pigmented tissue
08/16/2012US20120207800 Compositions
08/16/2012US20120207798 Solid Oral Dosage Form Attached to a Handle
08/16/2012US20120207797 Dosage forms for tamper prone therapeutic agents
08/16/2012US20120207795 Cationic polymer coated mesoporous silica nanoparticles and uses thereof
08/16/2012US20120207794 Water-soluble drug carrier and process for producing the same
08/16/2012US20120207792 Injectable filler for podiatric and orthopedic uses
08/16/2012US20120207791 Immobilized biologically active entities having a high degree of biological activity
08/16/2012US20120207784 Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine
08/16/2012US20120207773 Materials and methods for the development of an antigen-specific immune non-responsiveness state
08/16/2012US20120207770 Antiproliferative agent
08/16/2012US20120207769 Inhibitors of IAP
08/16/2012US20120207767 Combined Treatment with an EGFR Kinase Inhibitor and an Agent that Sensitizes Tumor Cells to the Effects of EGFR Kinase Inhibitors
08/16/2012US20120207766 Intracellular toll-like receptors pathways and axonal degeneration
08/16/2012US20120207765 Chemokine receptor antagonists and use thereof
08/16/2012US20120207763 Pyrrolopyrimidine compounds and their uses
08/16/2012US20120207762 Stable pharmaceutical formulations
08/16/2012US20120207758 CD22 Exon 12 Deletion Mutants
08/16/2012US20120207755 Cancer
08/16/2012US20120207751 Imidazoquinolines as lipid kinase inhibitors
08/16/2012US20120207744 Reprogramming compositions and methods of using the same
08/16/2012US20120207737 Medical utility of glycan-binding proteins and glycans
08/16/2012US20120207731 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same
08/16/2012US20120207730 Methods and Compositions for Treating Viral Hemorrhagic Fever
1 ... 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 ... 7860